Foresite Labs, LLC has bought ALMS on 5 days since Jul 2024

Foresite Labs, LLC is a center for entrepreneurial innovation at the nexus of data science, artificial intelligence, and healthcare, founded in 2019 and headquartered in San Francisco, California, with operations also in Boston.( The company partners with visionary entrepreneurs to incubate, build, and scale life sciences and healthcare ventures that leverage AI, data science, and advanced analytics to accelerate scientific discovery and address unmet medical needs, including immune-mediated diseases.( Foresite Labs operates as a biotechnology startup incubator, developing an ecosystem of companies tackling major challenges through AI-driven solutions, with a reported revenue of $14.8 million and 10-50 employees (previously noted as 70).(

As a corporate insider, Foresite Labs has recently engaged in significant transactions with Alumis Inc. (ALMS), a clinical-stage biopharmaceutical company it incubated, holding a notable position such as 10% ownership amid key developments like the acquisition of ACELYRIN's lonigutamab program for thyroid eye disease.( Leadership includes key appointments like Ian Tong, MD as Chief Clinical Officer (former Stanford professor), Mary Helen Black as VP and Head of Human Genomics (ex-Johnson & Johnson), and Uplaksh Kumar as COO.( Foresite Labs continues to drive innovation by integrating scientific rigor with technology to propel breakthroughs across industries.(

Written by Perplexity from public sources.